Global tuberculosis: Perspectives, prospects, and priorities

JAMA - Journal of the American Medical Association

Volumn 312, Issue 14, 2014, Pages 1393-1394

  Frieden, Thomas R ^a   Brudney, Karen F ^b   Harries, Anthonyd ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLONE DERIVATIVE; RIFAMPICIN;

ACID FAST BACTERIUM; AFRICA SOUTH OF THE SAHARA; DISEASE CONTROL; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HUMAN; INCIDENCE; LATENT TUBERCULOSIS; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NOTE; PATIENT MONITORING; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPUTUM SMEAR; TUBERCULOSIS; ANTIBIOTIC RESISTANCE; ARTICLE; COST OF ILLNESS; EPIDEMIC; HEALTH; INFECTION CONTROL; METHODOLOGY; WORLD HEALTH ORGANIZATION;

COST OF ILLNESS; DRUG RESISTANCE, BACTERIAL; EPIDEMICS; HUMANS; INCIDENCE; INFECTION CONTROL; PREVALENCE; TUBERCULOSIS; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84907696416     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.11450     Document Type: Note

References (8)

1. World Health Organization. Global tuberculosis report 2013. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656-eng.pdf?ua=1. Accessed August 21, 2014.
2. Liu Y, Li X, WangW, et al. Investigation of space-time clusters and geospatial hot spots for the occurrence of tuberculosis in Beijing. Int J Tuberc Lung Dis. 2012;16(4):486-491.
3. Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care X pert MTB/RIF testing for tuberculosis in primary care settings in Africa. Lancet. 2014;383(9915):424-435.
4. Botha E, Den Boon S, Verver S, et al. Initial default from tuberculosis treatment. Int J Tuberc Lung Dis. 2008;12(7):820-823.
5. Claassens MM, du Toit E, Dunbar R, et al. Tuberculosis patients in primary care do not start treatment. Int J Tuberc Lung Dis. 2013;17(5):603-607.
6. Davey Smith G, Ebrahim S, Frankel S. How policy informs the evidence. BMJ. 2001;322(7280):184-185.
7. Pasipanodya JG, Gumbo T. Ameta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients. Clin Infect Dis. 2013;57(1):21-31.
8. Galgalo T, Dalal S, Cain KP, et al. Tuberculosis risk among staff of a large public hospital in Kenya. Int J Tuberc Lung Dis. 2008;12(8):949-954.